TCOV
CRL icon

Trust Company of Vermont’s Charles River Laboratories CRL Stock Holding History

Trust Company of Vermont’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-135
Closed -$26.6K – 1063
2024
Q3 		$26.6K Hold
135
– – ﹤0.01% 611
2024
Q2 		$27.9K Sell
135
-13
-9% -$2.95K ﹤0.01% 563
2024
Q1 		$40.1K Buy
+148
New +$35.3K ﹤0.01% 517
2023
Q4 		– Sell
-135
Closed -$26.5K – 819
2023
Q3 		$26.5K Hold
135
– – ﹤0.01% 539
2023
Q2 		$28.4K Hold
135
– – ﹤0.01% 544
2023
Q1 		$27.2K Hold
135
– – ﹤0.01% 566
2022
Q4 		$29.4K Sell
135
-23
-15% -$5.02K ﹤0.01% 543
2022
Q3 		$31K Buy
158
+23
+17% +$4.96K ﹤0.01% 547
2022
Q2 		$29K Buy
+135
New +$33K ﹤0.01% 533
2022
Q1 		– Sell
-135
Closed -$51K – 400
2021
Q4 		$51K Buy
+135
New +$52.5K ﹤0.01% 482
2021
Q3 		– Sell
-135
Closed -$50K – 394
2021
Q2 		$50K Hold
135
– – ﹤0.01% 475
2021
Q1 		$39K Sell
135
-8
-6% -$2.22K ﹤0.01% 495
2020
Q4 		$36K Buy
143
+8
+6% +$1.91K ﹤0.01% 487
2020
Q3 		$31K Buy
+135
New +$28K ﹤0.01% 481

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Trust Company of Vermont's CRL Position: Q4 2024 in Review

Trust Company of Vermont sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 135 shares — an estimated $26.6K sold.

Trust Company of Vermont first reported a position in CRL in Q3 2020 and held it in 14 quarters. The position peaked at $51K in Q4 2021. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Trust Company of Vermont reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Trust Company of Vermont sold 135 Charles River Laboratories shares in Q4 2024, an estimated $26.6K.
  • Trust Company of Vermont first reported a position in Charles River Laboratories in Q3 2020 and held it in 14 quarters.
  • Trust Company of Vermont's Charles River Laboratories position peaked at $51K in Q4 2021.
  • 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Trust Company of Vermont's 13F filing for Q4 2024, filed 15 Jan 2025.